EUVIMEDEUVIMED entdecken
VergleichsstudieKohortenstudie

Comparison of the Effect of Proton Pump Inhibitors Versus Histamine-2 Receptor Antagonists on Cardiovascular Outcomes on Clopidogrel-Based Dual Antiplatelet Therapy: A Nationwide Cohort Study

Yu Jeong Lee iD, Nam Kyung Je iD

Annals of Pharmacotherapy · 2025

DOI: 10.1177/10600280251392989 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Annals of Pharmacotherapy, 2025. Verfasst von Yu Jeong Lee und 1 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Pusan National University, Busan, Republic of Korea. Hauptthemen laut MEDLINE: Proton Pump Inhibitors, Clopidogrel, Histamine H2 Antagonists, Platelet Aggregation Inhibitors. Die Arbeit nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Dual antiplatelet therapy (DAPT) is essential after percutaneous coronary intervention (PCI) but increases gastrointestinal (GI) bleeding risk, necessitating acid suppressants. The cardiovascular safety of concomitant proton pump inhibitor (PPI) use with clopidogrel has been debated due to potential drug-drug interactions, although recent evidence suggests that these concerns may be less clinically significant.

Objective

This study aimed to compare the risk of cardiovascular events and the prevention of GI bleeding associated with the use of PPIs with histamine type 2 receptor antagonists (H2RAs) in patients receiving clopidogrel after PCI, and to investigate potential differences among PPIs.

Methods

In this retrospective cohort study conducted in Korea, 75 600 patients who had been discharged after PCI between September 2017 and August 2020 and maintaining DAPT of aspirin-clopidogrel for at least 90 days were divided into 2 groups: 20 843 patients received PPIs and 4239 patients received H2RAs. Propensity score matching resulted in 4238 patients in each group. The major outcome was a composite of acute myocardial infarction, acute ischemic stroke, revascularization, and in-hospital death up to 2 years of discharge. The secondary outcomes included major GI bleeding.

Results

For the composite outcome, the incidence was not significantly higher in the PPIs group than in the H2RAs group (PPIs vs H2RAs after matching: 260 [6.13%] vs 197 [4.65%]; hazard ratio = 1.13; 95% confidence interval = 0.94, 1.36). No significant differences were observed in each outcome comprising the composite and bleeding outcome. Subgroup analysis stratified by CYP2C19 inhibition potential also showed no significant differences. Conclusion and Relevance: Concomitant use of PPIs was not significantly associated with increased cardiovascular outcomes compared with concomitant use of H2RAs, and no significant differences in the potential interaction with CYP2C19 were observed in real-world data. These findings suggest that potential pharmacokinetic interactions may have limited clinical impact.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proton Pump InhibitorsClopidogrelHistamine H2 AntagonistsPlatelet Aggregation InhibitorsGastrointestinal HemorrhageDual Anti-Platelet TherapyCardiovascular DiseasesHumansMaleFemaleRetrospective StudiesAgedDrug InteractionsPercutaneous Coronary InterventionMiddle AgedRepublic of KoreaCohort StudiesDrug Therapy, CombinationAspirin

Stichwörter der Autor:innen

MACEclopidogreldrug interactionsdual antiplatelet therapypercutaneous coronary interventionproton pump inhibitors

Substanzen

Proton Pump InhibitorsClopidogrelHistamine H2 AntagonistsPlatelet Aggregation InhibitorsAspirin

Autor:innen und Institutionen

  • College of Pharmacy, Pusan National University, Busan, Republic of Korea.
  • Department of Pharmacy, Pusan National University Hospital, Busan, Republic of Korea.

ORCID-Profile: Yu Jeong Lee, Nam Kyung Je

Zitieren

APA

Lee, Y. J., & Je, N. K. (2025). Comparison of the Effect of Proton Pump Inhibitors Versus Histamine-2 Receptor Antagonists on Cardiovascular Outcomes on Clopidogrel-Based Dual Antiplatelet Therapy: A Nationwide Cohort Study. Annals of Pharmacotherapy. https://doi.org/10.1177/10600280251392989

Vancouver

Lee YJ, Je NK. Comparison of the Effect of Proton Pump Inhibitors Versus Histamine-2 Receptor Antagonists on Cardiovascular Outcomes on Clopidogrel-Based Dual Antiplatelet Therapy: A Nationwide Cohort Study. Annals of Pharmacotherapy. 2025. doi:10.1177/10600280251392989

BibTeX
@article{Lee2025,
  author = {Lee, Yu Jeong and Je, Nam Kyung},
  title = {Comparison of the Effect of Proton Pump Inhibitors Versus Histamine-2 Receptor Antagonists on Cardiovascular Outcomes on Clopidogrel-Based Dual Antiplatelet Therapy: A Nationwide Cohort Study},
  journal = {Annals of Pharmacotherapy},
  year = {2025},
  doi = {10.1177/10600280251392989}
}
Kostenlos starten →